NDAORALTABLET, DELAYED RELEASE
Approved
Jul 2024
Lifecycle
Growth
Competitive Pressure
0/100
Clinical Trials
1
Data completeness
3/8 — Basic
Drug data last refreshed 8h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ZUNVEYL (benzgalantamine) is a delayed-release oral tablet approved by the FDA in July 2024 from sponsor AlphaCognition. Mechanism of action and therapeutic indications are not yet specified in available data. The product represents a novel formulation strategy in a growth-stage lifecycle.
Growth19.0 years to LOE
Early-stage growth product with zero reported competitor pressure signals a differentiated market position; commercial team buildout likely underway.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
Started May 2026
150 enrolled
Alzheimer Disease
Career Relevance
ZUNVEYL is a newly approved product with zero linked job postings currently, but career opportunity will expand as AlphaCognition scales launch infrastructure. The 19-year patent exclusivity window and zero competitive pressure create a rare opportunity to build a product from commercial inception with long-term tenure potential.
Brand Manager
Worked on ZUNVEYL at AlphaCognition? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.